Novartis Hit With $1.5M Whistleblower Verdict In NJ
By Bill Wichert (February 26, 2019, 1:01 PM EST) -- A New Jersey state jury on Tuesday slammed Novartis Pharmaceuticals Corp. with net damages totaling nearly $1.5 million over a former company executive's claims she was fired in retaliation for objecting to a proposed drug study, rejecting the pharmaceutical giant's stance that she was properly terminated for violating company policies.
On their third day of deliberations, the eight jurors mostly sided with Min Amy Guo in her whistleblower suit alleging she was fired for raising concerns in 2012 about the potential study of cancer drug Afinitor by pharmaceutical distribution company McKesson Corp., including that the study appeared to be a kickback...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!